Assembly

ASMB NASDAQ
15.37
+0.27
+1.79%
Pre Market: 15.37 0 0.00% 08:46 05/22 EDT
Open
15.23
Prev Close
15.10
High
15.72
Low
14.85
Volume
255
Avg Vol (3M)
350.42K
52 Week High
48.91
52 Week Low
13.13
% Turnover
1.11%
Market Cap
393.49M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers Assembly ASMB stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Assembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. It has discovered various core protein Allosteric Modulators (CpAMs), which are small molecules that directly target and allosterically modulate the HBV core (HBc) protein. Its Microbiome Program consists of an integrated platform that includes a strain identification and selection process, methods for strain isolation and growth under current good manufacturing practice conditions, and a delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal (GI) tract. The lead product candidate from this platform, AB-M101, is in development for the treatment of clostridium difficile-infections.
MORE >

Recently

Name
Price
%Change